Gross margin in the fourth quarter of 2024 remained steady at 86.4% during the fourth quarters ended December 31, 2024 and 2023. The Company maintained its gross margin by growing its higher margin ...

NeurAxis, Inc. ("NeurAxis," or the "Company") (NYSE American: NRXS), a medical technology company commercializing neuromodulation therapies for chronic ...

Abbott's Jenn Wong discusses the TRANSCEND trial for depression, imaging tech advancing DBS, and other potential applications ...

Source: Johns Hopkins University In the lab, the bionic hand identified and manipulated 15 everyday objects — such as stuffed ...

In clinical trials, almost 500 depression patients who were resistant to current treatments were given therapy that stimulated their vagus nerve. The major | Clinical And Molecular Dx ...

These are our top tested FaceGym, Foreo and NuFace facial toning devices, trialled by readers and in the lab, all with a ...

Tinnitus, the perception of ringing, buzzing, or clicking sounds without an external source, affects millions worldwide. It ...

Panhandle Power Solutions (PPS), a Member Company of Bristol Bay Industrial, LLC has been awarded a design-build contract by NASA to replace the B-Line overhead 15kV electrical distribution lines at ...

A patient who has received a surgery featuring an innovative brain-spinal interface technology poses for a group photo with ...

The company's new CEO joined the team last year from Medtronic, one of the largest medical device companies in the world.

Rebecca values exercise in rehabilitation and believes it can enhance physical, mental and social wellbeing. She uses ...

Even advanced brain-computer interfaces (BCIs), like those developed by Elon Musk’s Neuralink, assume that paralyzed limbs ...